Connect your AI

Ingevity NGVT Impairment charges for facilities consolidation

Impairment charges for facilities consolidation at other companies

Valero EnergyVLO

$0-100%

Meta Platforms, Inc.META

$0-100%

Monster BeverageMNST

$0-100%

LXP Industrial TrustLXP

$0—

IngredionINGR

$2.5M-90.8%

Halozyme TherapeuticsHALO

$12.18M—

Other financials

Income statement

Revenue$258.0M+4.1%

Gross profit$116.4M+4.0%

Net income$59.8M+192%

EPS (diluted)$1.66+196%

Balance sheet

Cash & equivalents$95.4M+5.0%

Total debt$1.4B-9.0%

Total equity$38.9M-83.4%

Total assets$1.7B-19.7%

Cash flow

Operating cash flow-$2.0M-108%

CapEx$10.3M+3.0%

Free cash flow-$12.3M-180%

Valuation

Market cap$2.53B+73.9%

Enterprise value$3.8B+32.4%

P/S2.1×+0.9×

Profitability

Gross margin39.3%+1.5pp

Net margin-10.6%-4.1pp

FCF margin20.3%+12.6pp

Returns & leverage

Return on equity-93.5%+1.2pp

Debt / equity35.1×+28.7×

Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The official record: Ingevity’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's impairment charges for facilities consolidation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ingevity's impairment charges for facilities consolidation?: Ingevity (NGVT) reported impairment charges for facilities consolidation of $27.33M in Q4 2025.